St. Jude Medical (STJ) Tops Q1 EPS by 2c; Guides Q1 EPS to Strong-Side of Views

St. Jude Medical (NYSE: STJ) reported Q1 EPS of $0.93, $0.02 better than the analyst estimate of $0.91. Revenue for the quarter came in at $1.35 billion versus the consensus estimate of $1.32 billion.

Outlook:

St. Jude Medical sees Q2 2015 EPS of $0.99 - $1.01, versus the consensus of $0.99.

St. Jude Medical sees FY2015 EPS of $3.92 - $3.97, versus the consensus of $3.95.

or the second quarter, St. Jude Medical expects revenue to grow in the range of 4 percent to 5 percent on a constant currency basis compared to the second quarter of 2014 with currency negatively impacting second quarter revenue by approximately $125 million to $135 million. For the full-year 2015, we expect total revenue to grow in the range of 4 percent to 5 percent on a constant currency basis with currency negatively impacting full-year 2015 revenue by approximately $385 million to $410 million. During its earnings conference call today, St. Jude Medical will provide an update to its range for revenue expectations for the full-year 2015 by product category.

For earnings history and earnings-related data on St. Jude Medical (STJ) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• The LGL Group (LGL) Misses Q2 EPS by 8c